Retarded diagnosis of myelopathy by HTLV-1, ¿are there early findings?
PDF (Español)
XML (Español)

Keywords

Spasticity
lymphotropic
myelopathy
paraparesis
retrovirus
(MeSH)

Abstract

A case of HTLV-I myelopathy is reported in an Afro-descendant patient in his sixth decade of life, from Popa-yán Cauca Colombia. It has not been typical symptomatology since years, but in the last months characteristic symptoms appear and it is when diagnosis of HTVL-1 is made by Elisa (9.51 positive). The disease progresses without the possibility of arrest and can only be offered analgesic management, physical therapy and comfort measures. The importance of making an early diagnosis for HTLV-1 and the need for intervention before the disease is disabling is discussed. We found two studies, one in Peru and one in Brazil, where two ways of objectively identifying early changes in seropositive patients.

https://doi.org/10.22379/24224022142

PDF (Español)
XML (Español)

References

Secretaría de Vigilancia de Salud, Programa Nacional de ITS Y SIDA. Guía de manejo clínico del paciente con HTLV [Internet]. Brasil - Brasilia DF: Ministerio de Salud. 2003. [Citado en 2004]. Disponible en: (https://es.scribd.com/document/327344550/ Guia-de-Manejo-Clinico-Do-Paciente-Com-Htlv-Espan-14890

>)

Poiesz B, Ruscetti F, Gazdar A, Bunn P, Minna J, Gallo R. Detection and isolation oflype C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous Tcell lymphoma. Proc Nad Acad Sci USA. 1980; 77(12): 7415-9.

Nakamura T. HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP): the role of HTLV-I-infected Th1 cells in the pathogenesis, and therapeutic strategy. Folia Neuropathol. 2009;47(2):182-94.

Nakamura T, Nishiura Y, Eguchi K. Therapeutic strategies in HTLV1 associated myelopathy/tropical spastic paraparesis (HAM/TSP). Cent Nerv Syst Agents Med Chem. 2009;9(2):137-49.

Zamora T, Lara B. Mielopatia HTLV-I positivo. Tribuna Médica. 1995;91(6):315-324.

Sanmartin C, Román G. HTLV-I en la costa del pacifico de Colombia y Ecuador. Tribuna Médica. 1995;92(1):15-22.

Franzoi A, Araújo A. Disability and determinants of gait performance in tropical spastic paraparesis/HTLV-I associated myelopathy (HAM/TSP). Spinal Cord. 2007;45(1):64-8. https://doi.org/10.1038/sj.sc.3101919

Castro N, Oliveira P, Freitas D, Rodrigues W, Muniz A, Carvalho E. Erectile dysfunction and HTLV-I infection: a silent problema. Int J Impot Res. 2005;17(4):364-69. https://doi.org/10.1038/sj.ijir.3901335

Zaninovic V, Moreno D, Payan C, Rodriguez A. A propósito de 5 casos de paraparesia espástica tropical en Puerto Tejada (Cauca). Colom Med.1997;28(2):67-70.

Rosero F, Aguirre C, Orjuela D, Rosero M. Paraparesia Espástica Tropical en un paciente con HTLV-I. Rev Med Risaralda. 2010;16(2):77-82. http://dx.doi.org/10.22517/25395203.821

Gessain A. Human retrovirus HTLV-1: descriptive and molecular epidemiology, origin, evolution, diagnosis and associated diseases. Bull Soc Pathol Exot. 2011;104(3): 167-180. http://dx.doi.org/10.1007/s13149-011-0174-4

Moreno C, Balangero M, Barbás M, Cudolá A, Gallego S. Diagnóstico serológico de HTLV-1/2: combinación de técnicas de tamizaje para definir el estatus serológico en donantes de sangre. Rev Argent Microbiol. 2013;45(3):165-845.

Cervilla J, Cartier L, García L. Resonancia Magnética de médula espinal y cerebro en el correlato clínico de la paraparesia espástica progresiva que se asocia al virus humano linfotrópico tipo-I (HTLV-I). Rev Méd Chile. 2006;134(8):1010-18. http://dx.doi.org/10.4067/S0034-98872006000800010

Kuroda Y, Fungiyama F, Nagumo F. Analysis of factors of relevance to rapid clinical progression in HTLV-1 associated mielopathy. J Neurol Sci. 1991;105(1):61-66.

Vernant J, Maurs L, Gout O, Buisson G, Plumelle Y, Neisson-Vernant C, et al. HTLV-1 associated tropical epastic paraparesia in Martinique: a reappraisal. Ann Neurol. 1988:(Suppl):S133-5.

Roman G, Roman L. Tropical spastic paraparesis. A clinical study of 50 patients from Tumaco (Colombia) and review of the world wide reatures of the síndrome. J Neurol Sci.1988;87(1):121-38.

Windsor I, Bill P, Bhigjee A, Haribhai H, Kelbe C, Hoffman M. et al. HTLV-I associated myelopathy in natal. S. Afr Med. 1988;74(7):370.

Zamora T, Szocs J, Zaninovic V. Paraparesia espástica tropical, artropatía inflamatoria crónica, lesión cerebral y carcinoma de vejiga en una paciente con HTLV-I. Acta Neurol Colomb. 2002;18(1):66-68.

Oropeza D, Zavala E, Vilca M. Dermatomiositis y Síndrome de Evans Asociado a Infección por HTLV-1. Rev Peru Med Exp Salud Pública. 2016;33(1):162-67. http://dx.doi.org/10.17843/rpmesp.2016.331.2018

Vasconcelos B, Souza G, Barroso T, Silveira L, Sousa R, Callegari B, et al. Barefoot Plantar Pressure Indicates Progressive Neurological Damage in Patients with Human T-Cell Lymphotropic Virus Type 1 Infection. PLoS One. 2016;11(3):e0151855. http://dx.doi.org/10.1371/journal.pone.0151855

Zunt J, Alarcón J, Montano S, Longstreth T, Price R, Holmes K. Quantitative assessment of subclinical spasticity in human T-cell lymphotropic virus type I infection. Neurology. 1999;53(2):386-90.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Downloads

Download data is not yet available.